Complete hypopharyngeal obstruction by mucosal adhesions: A complication of intensive chemoradiation for advanced head and neck cancer

Head and Neck

Volumn 28, Issue 8, 2006, Pages 663-670

  Franzmann, Elizabeth J ^a   Lundy, Donna S ^a   Abitbol, Andre A ^a,b   Goodwin, W Jarrard ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

Adhesions; Hypopharyngeal obstruction; Radiation chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; MITOMYCIN C; PACLITAXEL;

ADHESION; ADULT; ADVANCED CANCER; AGED; BARIUM MEAL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGOSCOPY; FEMALE; GASTROSTOMY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; HYPOPHARYNX OBSTRUCTION; LARYNGECTOMY; MALE; PHARYNX DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

ADHESIONS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; FEMALE; GASTROSTOMY; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNX; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PHARYNGEAL DISEASES; RADIOTHERAPY; RETROSPECTIVE STUDIES; TISSUE ADHESIONS; TREATMENT OUTCOME;

EID: 33746345601     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20392     Document Type: Review

References (30)

1. Abitbol A, Abdel-Wahab M, Lewin A, et al. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: a-2 protocol. Int J Radiat Oncol Biol Phys 2002;53:942-947.
2. Abitbol AA, Sridhar KS, Lewin AA, et al. Hyperfractionated radiation therapy and 5-flourouracil, cisplatin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma. Cancer 1997;80:266-276.
3. Machtay M, Rosenthal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 2002;20:3964-3971.
4. Vokes EE, Stenson K, Rosen FR, et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003;21:320-326.
5. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:1161-1171.
6. Smith RV, Kotz T, Beitler JJ, Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg 2000;126:384-389.
7. Grossman TW, Wilson JF, Toohill RJ. Delayed aerodigestive tract complications following combined therapy for thyroid cancer. Ann Otol Rhinol Laryngol 1985;94:505-508.
8. Posner MR, Weichselbaum RR, Fitzgerald TJ, et al. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1985;11:1887-1893.
9. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2002;53:23-28.
10. Umsawasdi T, Valdivieso M, Barkley T, et al. Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1985;11:511-519.
11. Nageris B, Elidan J, Sichel J. Aerodigestive tract obstruction as a late complication of radiotherapy. J Laryngol Otolaryngol 1995;109:68-69.
12. Sunwoo JB, Herscher LL, Kroog GS, et al. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol 2001;19:800-811.
13. Raju GS, Ahmed I, Bunting E, Tsue TT. A novel approach to radiation-induced post-cricoid esophageal stricture: the "Laryngeal Jack" to facilitate dilatation. Gastrointest Endosc 2000;52:282-285.
14. Lew RJ, Shah JN, Chalian A, Weber RS, Williams NN, Kochman ML. Technique of endoscopic retrograde puncture and dilatation of total esophageal stenosis in patients with radiation-induced strictures. Head Neck 2004;26:179-183.
15. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996;14:838-847.
16. Stell PM, Rawson NSB. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990;61:778-787.
17. Munro AJ. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
18. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949-955.
19. Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L, and the Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579-589.
20. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
21. Abitbol AA, Friedland JL, Lewin AA, Rodrigues M, Mishra V. (1999). Radiation therapy in oncologic management with special emphasis on head and neck carcinoma. In: Sullivan PA, Guilford AM, editors. Swallowing intervention in oncology. Singular Publishing Group, Inc.; San Diego, CA, p 47-64.
22. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47:1-12.
23. Peters LJ, Ang KK, Thames HD. Accelerated fractionation in the radiation treatment of head and neck cancer. Acta Oncol 1988;27:185-194.
24. Common Terminology Criteria for Adverse Events v 3.0 (CTCAE) Retrieved April 22, 2005. http://ctep.cancer.gov/reporting/ctc.html.
25. Symonds RP. Treatment-induced mucositis: and old problem with new remedies. Br J Cancer 1998;77:1689-1695.
26. Bourhis J, Rosine D. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Semin Oncol 2002;29:61-62.
27. Sawyer R. Treatment of upper esophageal strictures. Otolaryngol Head Neck Surg 1985;93:379-384.
28. Goodwill WJ, Lundy DS, Livingstone AS. Reconstruction of the stenotic hypopharynx and cervical esophagus without total laryngectomy. Laryngoscope 1984;94:1153-1157.
29. Fabian RL. Reconstruction of the laryngopharynx and cervical esophagus. Laryngoscope 1984;94:1334-1350.
30. Logemann JA, Rademaker AW, Pauloski BR, Kahrilas PJ. Effects of postural change on aspiration in head and neck surgical patients. Otolaryngol Head Neck Surg 1994;110:222-227.